{"id":145,"date":"2020-05-05T05:48:17","date_gmt":"2020-05-05T05:48:17","guid":{"rendered":"https:\/\/nclinnovations.org\/covid19monitor\/?p=145"},"modified":"2020-05-05T05:48:17","modified_gmt":"2020-05-05T05:48:17","slug":"02-may-2020-hydroxychloroquine-slower-viral-clearance-with-hcq-use-in-covid-19-patients","status":"publish","type":"post","link":"https:\/\/nclinnovations.org\/covid19monitor\/02-may-2020-hydroxychloroquine-slower-viral-clearance-with-hcq-use-in-covid-19-patients\/","title":{"rendered":"(02 May 2020) Hydroxychloroquine- slower viral clearance with HCQ use in COVID-19 patients"},"content":{"rendered":"<div class=\"boldgrid-section\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-12 col-xs-12 col-sm-12\">\n<p class=\"\">Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: A retrospective study<\/p>\n<p><a href=\"https:\/\/doi.org\/10.1101\/2020.04.27.20082180\">https:\/\/doi.org\/10.1101\/2020.04.27.20082180<\/a><\/p>\n<p class=\"\">In a retrospective observational study at Cleveland Clinic Abu Dhabi assessment of the efficacy of HCQ&nbsp; w.r.t&nbsp; SARS-CoV-2 viral clearance was done.The primary outcome was the time from a confirmed positive nasopharyngeal swab to turn negative. 34 confirmed COVID-19 patients were included. Nineteen (55.9%) patients presented with symptoms, and 14 (41.2%) had pneumonia. Only 21 (61.8%) patients received HCQ. The time to SARS-CoV-2 negativity nasopharyngeal test was significantly longer in patients who received HCQ compared to those who did not receive HCQ (17 [13-21] vs. 10 [4-13] days, p=0.023).<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: A retrospective study https:\/\/doi.org\/10.1101\/2020.04.27.20082180 In a retrospective observational study at Cleveland Clinic Abu Dhabi assessment of the efficacy of HCQ&nbsp; w.r.t&nbsp; SARS-CoV-2 viral clearance&hellip; <span class=\"read-more-span\"><a href=\"https:\/\/nclinnovations.org\/covid19monitor\/02-may-2020-hydroxychloroquine-slower-viral-clearance-with-hcq-use-in-covid-19-patients\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;(02 May 2020) Hydroxychloroquine- slower viral clearance with HCQ use in COVID-19 patients&#8221;<\/span> <span class=\"genericon genericon-next\"><\/span><\/a><\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"bgseo_title":"","bgseo_description":"","bgseo_robots_index":"index","bgseo_robots_follow":"follow"},"categories":[4,9],"tags":[10],"_links":{"self":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/145"}],"collection":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/comments?post=145"}],"version-history":[{"count":1,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/145\/revisions"}],"predecessor-version":[{"id":146,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/145\/revisions\/146"}],"wp:attachment":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/media?parent=145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/categories?post=145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/tags?post=145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}